Common Contracts
17 similar Subscription Agreement contracts by Akoustis Technologies, Inc., Enumeral Biomedical Holdings, Inc., Tapimmune Inc, Ekso Bionics Holdings, Inc.
SUBSCRIPTION AGREEMENTSubscription Agreement • January 16th, 2018 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 2,800,000 shares (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of US$5.50 per Share of Common Stock (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • January 16th, 2018 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by Tiburon Opportunity Fund LP (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 2,800,000 shares (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of US$5.50 per Share of Common Stock (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • January 16th, 2018 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 3,269,727 shares (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price per Share equal to the most recent closing price per share of Common Stock immediately preceding the applicable Closing (as defined below) (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • January 16th, 2018 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 2,800,000 shares (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of US$5.50 per Share of Common Stock (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • January 16th, 2018 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 3,269,727 shares (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price per Share equal to the most recent closing price per share of Common Stock immediately preceding the applicable Closing (as defined below) (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • January 16th, 2018 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 2,800,000 shares (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of US$5.50 per Share of Common Stock (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • June 22nd, 2017 • Tapimmune Inc • Pharmaceutical preparations • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by TapImmune Inc., a Nevada corporation (the “Company”), of Units (“Units”), with each Unit consisting of one share of the Company’s common stock (“Common Stock”), par value $0.001 per share (each, a “Share”) and one five-year warrant to purchase one share of Common Stock with an exercise price equal to the Market Value (as defined below) (each an “Investor Warrant”). The price per Unit (the “Purchase Price”) will be equal to “Market Value,” as defined below, plus $0.125. The $0.125 will be allocated to the warrant included in the Unit, and the remainder of the Purchase Price will be allocated to the Share of Common Stock. “Market Value” is defined as the consolidated closing bid price per share of the Common Stock on the Nasdaq Stock Market immediately preceding the Company’s acce
SUBSCRIPTION AGREEMENTSubscription Agreement • May 25th, 2017 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 600,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of $9.00 per Share (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • May 25th, 2017 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 700,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of $9.00 per Share (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • February 14th, 2017 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Delaware corporation (the “Company”) of up to 2,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of $5.00 per Share (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • February 14th, 2017 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Nevada corporation (the “Company”) of up to 2,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), at a purchase price of $5.00 per Share (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • August 11th, 2016 • Tapimmune Inc • Pharmaceutical preparations • New York
* For purposes of calculating your net worth in this form, (a) your primary residence shall not be included as an asset; (b) indebtedness secured by your primary residence, up to the estimated fair market value of your primary residence at the time of your purchase of the securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of your purchase of the securities exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of your primary residence, the amount of such excess shall be included as a liability); and (c) indebtedness that is secured by your primary residence in excess of the estimated fair market value of your primary residence at the time of your purchase of the securities shall be included as a liability.
SUBSCRIPTION AGREEMENTSubscription Agreement • April 20th, 2016 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Akoustis Technologies, Inc., a Nevada corporation (the “Company”) of shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) issued, at a purchase price of $1.60 per Share (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • May 29th, 2015 • Akoustis Technologies, Inc. • Services-prepackaged software • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) by Danlax, Corp. (intended to be renamed Akoustis Technologies, Inc.), a Nevada corporation (the “Company”) of a minimum of $3,000,000 (the “Minimum Offering”)1 and a maximum of $6,000,000 (the “Maximum Offering”) of shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) issued, at a purchase price of $1.50 per Share (the “Purchase Price”). This subscription is being submitted to you in accordance with and subject to the terms and conditions described in this Agreement, the Confidential and Non-Binding Summary Term Sheet of the Company dated April 17, 2015, relating to the Offering (as the same may be amended or supplemented, the “Term Sheet”), and any other Disclosure Materials (as defined below). The minimum subscription is $90,000 (60,00
SUBSCRIPTION AGREEMENTSubscription Agreement • August 8th, 2014 • Enumeral Biomedical Holdings, Inc. • Services-computer programming, data processing, etc. • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) of a minimum of $10,000,000 (the “Minimum Offering”) and a maximum of $15,000,000 (the “Maximum Offering”) of Units of securities (the “Units”), plus up to an additional $5,000,000 of Units to cover over-allotments, issued by Cerulean Group, Inc., a Nevada corporation (the “Company”), at a purchase price of $1.00 per Unit (the “Purchase Price”). Each Unit consists of (i) one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) a warrant, substantially in the form of Exhibit A hereto (the “Warrant”), representing the right to purchase one share of Common Stock, exercisable from issuance until five (5) years after the initial Closing of the Offering at an exercise price of $2.00 per share. This subscription is being submitted to you in accordance
SUBSCRIPTION AGREEMENTSubscription Agreement • August 7th, 2014 • Enumeral Biomedical Holdings, Inc. • Services-computer programming, data processing, etc. • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) of a minimum of $10,000,000 (the “Minimum Offering”) and a maximum of $15,000,000 (the “Maximum Offering”) of Units of securities (the “Units”), plus up to an additional $5,000,000 of Units to cover over-allotments, issued by Cerulean Group, Inc., a Nevada corporation (the “Company”), at a purchase price of $1.00 per Unit (the “Purchase Price”). Each Unit consists of (i) one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) a warrant, substantially in the form of Exhibit A hereto (the “Warrant”), representing the right to purchase one share of Common Stock, exercisable from issuance until five (5) years after the initial Closing of the Offering at an exercise price of $2.00 per share. This subscription is being submitted to you in accordance
SUBSCRIPTION AGREEMENTSubscription Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) of a minimum of $12,000,000 (the “Minimum Offering”) and a maximum of $20,000,000 (the “Maximum Offering”) of Units of securities (the “Units”), plus up to an additional $5,000,000 of Units to cover over-allotments, issued by PN Med Group Inc., a Nevada corporation (the “Company”), at a purchase price of $1.00 per Unit (the “Purchase Price”). Each Unit consists of (i) one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) a warrant, substantially in the form of Exhibit A hereto (the “Warrant”), representing the right to purchase one share of Common Stock, exercisable from issuance until five (5) years after the initial Closing of the Offering at an exercise price of $2.00 per share. This subscription is being submitted to you in accordance wi
